BNTX
Price
$96.97
Change
+$0.12 (+0.12%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
24.89B
32 days until earnings call
Intraday BUY SELL Signals
MSLE
Price
$8.50
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
186.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTX vs MSLE

BNTX vs MSLE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BNTX vs. MSLE commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a StrongBuy and MSLE is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BNTX vs MSLE: Fundamental Ratings
BNTX
MSLE
OUTLOOK RATING
1..100
7455
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
5334
P/E GROWTH RATING
1..100
120
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNTX's Valuation (2) in the null industry is somewhat better than the same rating for MSLE (47). This means that BNTX’s stock grew somewhat faster than MSLE’s over the last 12 months.

BNTX's Profit vs Risk Rating (100) in the null industry is in the same range as MSLE (100). This means that BNTX’s stock grew similarly to MSLE’s over the last 12 months.

BNTX's SMR Rating (93) in the null industry is in the same range as MSLE (98). This means that BNTX’s stock grew similarly to MSLE’s over the last 12 months.

MSLE's Price Growth Rating (34) in the null industry is in the same range as BNTX (53). This means that MSLE’s stock grew similarly to BNTX’s over the last 12 months.

BNTX's P/E Growth Rating (1) in the null industry is in the same range as MSLE (20). This means that BNTX’s stock grew similarly to MSLE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNTXMSLE
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
70%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BNTX: $96.85 vs. MSLE: $8.50)
Brand notoriety: BNTX and MSLE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 57% vs. MSLE: 182%
Market capitalization -- BNTX: $24.89B vs. MSLE: $186.67M
BNTX [@Biotechnology] is valued at $24.89B. MSLE’s [@Biotechnology] market capitalization is $186.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green while MSLE’s FA Score has 1 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • MSLE’s FA Score: 1 green, 4 red.
According to our system of comparison, MSLE is a better buy in the long-term than BNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 3 TA indicator(s) are bullish while MSLE’s TA Score has 3 bullish TA indicator(s).

  • BNTX’s TA Score: 3 bullish, 6 bearish.
  • MSLE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MSLE is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а -2.43% price change this week, while MSLE (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BNTX
Daily Signal:
Gain/Loss:
MSLE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FIGG16.200.81
+5.26%
Leverage Shares 2x Long FIG Daily ETF (FIGG)
PSFF35.190.08
+0.23%
Pacer Swan SOS Fund of Funds ETF (PSFF)
DLN97.260.06
+0.06%
WisdomTree U.S. LargeCap Dividend Fund (DLN)
CHGX33.05N/A
N/A
EA SERIES TRUST STANCE SUSTAINABLE BETA ETF
INDL38.98-0.53
-1.34%
Direxion Daily MSCI India Bull 2X ETF (INDL)

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.48%
MRNA - BNTX
60%
Loosely correlated
-1.89%
NVAX - BNTX
43%
Loosely correlated
-1.94%
AXON - BNTX
43%
Loosely correlated
-0.07%
CRSP - BNTX
42%
Loosely correlated
+0.22%
MRVI - BNTX
40%
Loosely correlated
-2.09%
More

MSLE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSLE
1D Price
Change %
MSLE100%
N/A
ANL - MSLE
40%
Loosely correlated
-1.50%
RVMD - MSLE
27%
Poorly correlated
+0.31%
BNTX - MSLE
26%
Poorly correlated
-1.48%
ACHV - MSLE
25%
Poorly correlated
-6.92%
IPSC - MSLE
23%
Poorly correlated
-5.85%
More